Bitcoin price today: dips to $92k ahead of PCE inflation, potential Fed cut
Adam David Sachs, President at Vicarious Surgical Inc. (NASDAQ:RBOT), sold 463 shares of Class A Common Stock on December 3, 2025, for a total of $1366. The shares were sold at a weighted average price of $2.952, with individual sales prices ranging from $2.715 to $3.34. RBOT currently trades at $3, near its 52-week low of $2.44, having fallen nearly 80% over the past year according to InvestingPro data.
Following the transaction, Sachs directly owns 47,885 shares of Vicarious Surgical Inc. With a market capitalization of just $19.19 million, the company appears undervalued based on InvestingPro Fair Value estimates, despite rapidly burning through cash.
The sale was executed to cover tax withholding obligations related to the vesting of restricted stock units granted on June 2, 2023. This transaction was mandated by Vicarious Surgical Inc.’s equity incentive plan, which requires tax obligations to be met through a "sell to cover" arrangement. Despite financial challenges, RBOT maintains a strong current ratio of 4.75, with liquid assets exceeding short-term obligations. For comprehensive analysis of RBOT and 1,400+ other stocks, explore InvestingPro Research Reports.
In other recent news, Vicarious Surgical Inc. reported its Q3 2025 earnings, noting a significant reduction in operating expenses and a narrower net loss compared to the same period last year. This improvement is part of the company’s ongoing efforts to develop its surgical robotic systems while managing expenses through workforce reductions and exploring outsourcing opportunities. Additionally, Vicarious Surgical has revised its 2025 cash burn guidance to approximately $45 million, down from the previous estimate of $50 million. The company attributes this improved outlook to disciplined cost management initiatives as part of an operational reset. Vicarious Surgical plans to provide guidance for its 2026 cash burn before the end of this year. These recent developments highlight the company’s focus on cost efficiency and strategic planning.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.